152 related articles for article (PubMed ID: 25256248)
1. Identification of biomarkers for radiation-induced acute intestinal symptoms (RIAISs) in cervical cancer patients by serum protein profiling.
Chai Y; Wang J; Gao Y; Wang T; Shi F; Su J; Yang Y; Zhou X; Song L; Liu Z
J Radiat Res; 2015 Jan; 56(1):134-40. PubMed ID: 25256248
[TBL] [Abstract][Full Text] [Related]
2. Application of 1H NMR spectroscopy-based metabonomics to feces of cervical cancer patients with radiation-induced acute intestinal symptoms.
Chai Y; Wang J; Wang T; Yang Y; Su J; Shi F; Wang J; Zhou X; He B; Ma H; Liu Z
Radiother Oncol; 2015 Nov; 117(2):294-301. PubMed ID: 26277430
[TBL] [Abstract][Full Text] [Related]
3. Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy.
Li GH; Wang DL; Hu YD; Pu P; Li DZ; Wang WD; Zhu B; Hao P; Wang J; Xu XQ; Wan JQ; Zhou YB; Chen ZT
Med Oncol; 2010 Sep; 27(3):919-25. PubMed ID: 19757213
[TBL] [Abstract][Full Text] [Related]
4. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
5. Serum biomarker screening for the diagnosis of early gastric cancer using SELDI-TOF-MS.
Li P; Zhang D; Guo C
Mol Med Rep; 2012 Jun; 5(6):1531-5. PubMed ID: 22427025
[TBL] [Abstract][Full Text] [Related]
6. [Application of SELDI-TOF serum proteome profiling in cervical squamous cell carcinoma].
Xia T; Zheng ZG; Gao Y; Mou HZ; Xu SH; Zhang P; Zhu JQ
Ai Zheng; 2008 Mar; 27(3):279-82. PubMed ID: 18334117
[TBL] [Abstract][Full Text] [Related]
7. Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry.
Liu Q; Chen X; Hu C; Zhang R; Yue J; Wu G; Li X; Wu Y; Wen F
Lung; 2010; 188(1):15-23. PubMed ID: 20012079
[TBL] [Abstract][Full Text] [Related]
8. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
9. [Proteinchip-flight mass spectrometry for screening differentially expressed proteins in the serum of cervical cancer patients].
Cai SN; Liu GB; Guo XH; Chen JG; Zhang J; Wu YL; Liang WJ; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):32-5. PubMed ID: 19218106
[TBL] [Abstract][Full Text] [Related]
10. A multi-omics approach based on
Yanlan C; Jielili A; Wang J; Tang H; Liu Z; Wang P
Aging (Albany NY); 2022 Sep; 15(6):1878-1889. PubMed ID: 36170024
[TBL] [Abstract][Full Text] [Related]
11. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
[TBL] [Abstract][Full Text] [Related]
12. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
13. [Application of SELDI-TOF-MS in establishing a model for predicting radiotherapy response of hypopharyngeal cancers].
Tian WD; Zeng ZY; Yu WB; Li XP
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1282-7. PubMed ID: 20584658
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
15. New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Liu JY; Jin L; Zhao MY; Zhang X; Liu CB; Zhang YX; Li FJ; Zhou JM; Wang HJ; Li JC
Clin Chem Lab Med; 2011 Oct; 49(10):1727-33. PubMed ID: 21671803
[TBL] [Abstract][Full Text] [Related]
16. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
17. SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis.
Cheng L; Zhou L; Tao L; Zhang M; Cui J; Li Y
J Cancer Res Clin Oncol; 2008 Jul; 134(7):769-76. PubMed ID: 18202856
[TBL] [Abstract][Full Text] [Related]
18. Potential proteomic biomarkers in assessing liver fibrosis using SELDI-TOF MS.
Karatayli SC; Alagöz SG; Mizrak D; Sayki M; Ozkan M; Savaş B; Erden E; Cinar K; Idılman R; Yurdaydin C; Bozdayi AM
Turk J Gastroenterol; 2012 Feb; 23(1):46-53. PubMed ID: 22505379
[TBL] [Abstract][Full Text] [Related]
19. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer.
Han M; Dai J; Zhang Y; Lin Q; Jiang M; Xu X; Liu Q; Jia J
Oncol Rep; 2012 Dec; 28(6):2233-8. PubMed ID: 22992788
[TBL] [Abstract][Full Text] [Related]
20. SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer.
Qian JY; Mou SH; Liu CB
Asian Pac J Cancer Prev; 2012; 13(5):1911-5. PubMed ID: 22901146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]